Iradimed Corporation
Price
FilingsNewest: 8-K/A, Results of operationsAug 18 →InsidersNo open-market buys. 5 insiders sold $20.0M, 79 of 124 sales on a 10b5-1 plan.→HoldersBlackRock 7.6%Kayne Anderson Rudnick 3.1%Renaissance Technologies 3.1%→PeersClosest companies: PROF, HYPR, ANGO→
From the filings
Figures
- Revenue
- $86.3Mlast 12 months
- Net income
- $23.1Mlast 12 months
- Operating cash flow
- $28.9Mlast 12 months
- Cash and equivalents
- $59.1Mat the last balance sheet
- Shares outstanding
- 12.8M shareson issue